Literature DB >> 21747627

Imiquimod as an adjuvant treatment measure for desmoplastic trichoepithelioma.

Sang-Hee Seo1, Gun-Wook Kim, Hyun-Woo Sung.   

Abstract

Desmoplastic trichoepithelioma is a rare benign adnexal tumor. Although it is a benign lesion, patients often want to treat it due to cosmetic concerns when it occurs in an easily visible site. For our two cases, topical 5% imiquimod was an attractive treatment option as it is applied by the patients themselves and it has minimal side effects, including leaving no scar. However, the lesions recurred after clinical remission. To the best of our knowledge, this is the only report on utilizing imiquimod to treat a benign adnexal tumor, and especially desmoplastic trichoepithelioma.

Entities:  

Keywords:  Adjuvant therapy; Desmoplastic trichoepithelioma; Imiquimod; Recurrence

Year:  2011        PMID: 21747627      PMCID: PMC3130871          DOI: 10.5021/ad.2011.23.2.229

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  8 in total

Review 1.  Imiquimod: modes of action.

Authors:  Donna Bilu; D N Sauder
Journal:  Br J Dermatol       Date:  2003-11       Impact factor: 9.302

Review 2.  Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream.

Authors:  Ju-Hyun Jo; Hyun-Chang Ko; Ho-Sun Jang; Moon-Bum Kim; Chang-Keun Oh; Kyung-Sool Kwon
Journal:  Dermatol Surg       Date:  2005-08       Impact factor: 3.398

3.  Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream.

Authors:  Soo-Jin Ahn; Hyun-Ju Lee; Sung-Eun Chang; Mi-Woo Lee; Jee-Ho Choi; Kee-Chan Moon; Jai-Kyoung Koh
Journal:  J Dermatol       Date:  2007-02       Impact factor: 4.005

4.  Multiple scrotal epidermolytic acanthomas successfully treated with topical imiquimod.

Authors:  Bong-Seok Jang; Ho-Sun Jang; Hyun-Je Park; Moon-Bum Kim; Chang-Keun Oh; Kyung-Sool Kwon
Journal:  J Dermatol       Date:  2007-04       Impact factor: 4.005

5.  The use of the 1.0 mm handpiece in high energy, pulsed CO2 laser destruction of facial adnexal tumors.

Authors:  F P Sajben; E V Ross
Journal:  Dermatol Surg       Date:  1999-01       Impact factor: 3.398

6.  Treatment of multiple trichoepithelioma with electrosurgery.

Authors:  M Shaffelburg; R Miller
Journal:  Dermatol Surg       Date:  1998-10       Impact factor: 3.398

7.  Desmoplastic trichoepithelioma.

Authors:  M H Brownstein; L Shapiro
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

8.  Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.

Authors:  Tomoki Ito; Ryuichi Amakawa; Tsuneyasu Kaisho; Hiroaki Hemmi; Kenichirou Tajima; Kazutaka Uehira; Yoshio Ozaki; Hideyuki Tomizawa; Shizuo Akira; Shirou Fukuhara
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

  8 in total
  1 in total

1.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.